Emtricitabine is a nucleoside reverse-transcriptase inhibitor used as an active pharmaceutical ingredient in the manufacturing of medications for HIV infection. It is an analog of the nucleoside cytidine and is supplied as a pharmaceutical raw material for formulation development.
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 143491-57-0
Auristatin 0101
Antibody-drug conjugate payload
Zidebactam
beta-lactamase inhibitor antibiotic adjuvant
Methoxy Eltrombopag
Thrombopoietin receptor agonist
Bis((2S,4S,5S,7S)-5-amino-N-(3-amino-2,2-dimethyl-3-oxopropyl)-4-hydroxy-7-[hydroxy-[4-methoxy-3-(3-methoxypropoxy)phenyl]methyl]-8-methyl-2-propan-2-ylnonanamide);(E)-but-2-enedioic acid
active pharmaceutical ingredient impurity
(+)-2'-Deoxy-3'-thia-5-fluorocytidine
active pharmaceutical ingredient
Emtricitabine Carboxylic Acid
Pharmaceutical impurity reference standard
Lamivudin
antiviral active pharmaceutical ingredient
Lamivudine impurity A RS
Lamivudine impurity reference standard
4-amino-5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one
XQSPYNMVSIKCOC-NTSWFWBYSA-N
C1[C@H](O[C@H](S1)CO)N2C=C(C(=NC2=O)N)F